ACTRIS

The Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) is the national center of excellence established to meet the growing demand for cell and gene therapy (CGT) in Singapore. Operating under the Consortium for Clinical Research and Innovation, Singapore (CRIS), ACTRIS provides a comprehensive suite of services including GMP manufacturing, process development, and regulatory consultancy. The facility features state-of-the-art cleanrooms designed to support both clinical trials and the commercialization of advanced therapeutic products. By bridging the gap between academic research and clinical application, ACTRIS plays a pivotal role in Singapore's biotech ecosystem. The institute focuses on enabling the delivery of safe and effective cell-based treatments for oncology and regenerative medicine.